Profile photo Louis Bont

Louis Bont

Full Professor

Strategic program(s):

Biography

Louis Bont is a Paediatrician Infectiologist at the Wilhelmina Children’s Hospital in the University Medical Center Utrecht, The Netherlands. He leads the Utrecht RSV Research Group. He is the coordinator of the Interest Group on Respiratory Infections of the European Society of Pediatric Infectious Diseases (ESPID) Research Committee. Dr. Bont is the founder and chairman of ReSViNET, an international RSV Research consortium. He has a strong interest in education of young talented researchers and founded the successful Training of Upcoming Leaders in Pediatric Science (TULIPS) career training program in the Netherlands. Dr. Bont served as advisor of the World Health Organization (WHO), the European Center of Disease Control (ECDC) and the Europarliament.

Louis Bont did his medical training at the Academic Medical Center in Amsterdam (1989-1996). He performed his PhD under the supervision of professor Jan Kimpen and professor Cobi Heijnen at the Wilhelmina Children’s Hospital (1997-2000). He was a post-doc at the Garofalo lab in Galveston, Texas (2000-2001). After returning to Utrecht, he followed the pediatric residency program followed by a pediatric infectious diseases and immunology fellowship. He have led the RSV Research Group since 2003 and became full professor in 2015.

The vision of his research is to combine clinical and basic research to decrease the global burden of RSV infection. The mission of his research group is to improve knowledge of RSV epidemiology, and to develop safe and effective therapeutic and preventive interventions.

In his work collaborate with patients is of highest importance. His work is supported by the RSV Patient Advisory Board (PAB) since 2012. The PAB has reviewed every grant application by the RSV Research Group. PAB members have been interviewed for newspapers and national television on RSV-related subjects.

Louis Bont actively participates as a teacher in the SUMMA program. In addition, he founded the TULIPS program in 2008 to train colleagues and young clinician-scientists.

Since April 1st 2021, Louis has been given a new position as medical scientific division manager of the Children's Division of the Wilhelmina Children's Hospital in Utrecht.

Research groups

Utrecht RSV research group

Research aim

We have the vision to combine clinical and basic research to decrease the global burden of RSV infection. Our mission is to improve knowledge of RSV epidemiology, to develop safe and effective interventions and to strive for global health equity.

Go to group

Pediatric immunology team

Research aim

The pediatric immunology team focuses on the under-explored research field of immune response modification for the prevention of immune-driven diseases. The goal of our research is to develop interventions that can prevent disease manifestations.

Go to group

Recent publications

Estimating the economic burden of respiratory syncytial virus infection among children <2 years old receiving care in Maputo, Mozambique Neele Rave, Tufária Mussá, An Nguyen, Clint Pecenka, Farina L. Shaaban, Louis J. Bont
Journal of Global Health, 2025, vol. 15
Assessing the cost of illness of RSV and non-RSV acute respiratory infections in Nepali children Neele Rave, Arun K. Sharma, Ram H. Chapagain, Rupesh Shrestha, An Nguyen, Clint Pecenka, Farina L. Shaaban, Prakash Joshi, Louis Bont,
Journal of Global Health, 2025, vol. 15
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development E Z Siegal, J M H Schoevers, J Terstappen, E M Delemarre, S L Johnston, L F van Beek, D Bogaert, C Chiu, D A Diavatopoulos, D M Ferreira, S B Gordon, F G Hayden, M I de Jonge, M B B McCall, H I McShane, A M Minassian, P J M Openshaw, A J Pollard, J Sattabongkot, R C Read, A Troelstra, M C Viveen, A Wilder-Smith, M van Wijk, L J Bont, N I Mazur
npj Vaccines, 2025, vol. 10
Proof-of-principle of a technology transfer of a dried blood virus neutralisation assay to a Gavi-eligible country Evangeline Obodai, Jonne Terstappen, Jude Yayra Mensah, Anouk Versnel, Comfort Nuamah Antwi, Louis J. Bont, Daniela Cianci, Eveline M. Delemarre, John Kofi Odoom, Peter M. Van De Ven, Natalie I. Mazur
BMJ global health, 2025, vol. 10
Efficacy and safety of SARS-CoV-2 vaccination in pregnancy to prevent COVID-19 in mothers and early infancy Odette de Bruin, Emily Wem Phijffer, Fariba Ahmadizar, Nicoline At Van der Maas, Joanne G Wildenbeest, Miriam Cjm Sturkenboom, Louis J Bont, Carlos E Durán, Kitty Wm Bloemenkamp
The Cochrane database of systematic reviews, 2025, vol. 2025, p.1-12
The respiratory microbiome is linked to the severity of RSV infections and the persistence of symptoms in children Maartje Kristensen, Wouter A.A. de Steenhuijsen Piters, Joanne Wildenbeest, Marlies A. van Houten, Roy P. Zuurbier, Raiza Hasrat, Kayleigh Arp, Mei Ling J.N. Chu, Marie Billard, Terho Heikkinen, Steve Cunningham, Matthew Snape, Simon B. Drysdale, Ryan S. Thwaites, Federico Martinon-Torres, Andrew J. Pollard, Peter J.M. Openshaw, Jeroen Aerssen, Justyna Binkowska, Louis Bont, Debby Bogaert,
Cell Reports Medicine, 2024, vol. 5

Fellowships & Awards

Full Professor (“Stimuleringshoogleraarschap”), expected in May 2015

International Congress of Pediatric Pulmunology (CIPP) Award for Contribution to Understanding Childhood Respiratory Disease and Global Medical Education (2013)

Dirkzwager-Assink Fonds Award by Catharijne Stichting for research on RSV bronchiolitis (2010)

Ter Meulen Fonds lecture: It is not all asthma that wheezes. 27e Congres Nederlandse Vereniging voor Kindergeneeskunde, Veldhoven (2005)

ESPID Fellowship Award 2001 Immunopathogenetic mechanisms of RSV infection in the mouse model (2001)

Royal Dutch Academy of Science (Ter Meulen Fonds Stipendium). Immunopathogenetic mechanisms of RSV infection in the mouse model (2000)

External positions

Chair and expert board member - Expertise RSV - ReSViNET – Respiratory Syncytial Virus Foundation

Global virtual advisory board - consulting - Janssen

Member Advisory Board - Clinical & Research Expertise - GlaxoSmithKline